Alexandre Hentz

Alexandre Hentz is a Senior Research Scientist and Project Leader at Evotec, specializing in Antibody Drug Conjugates (ADC) and Bioconjugation since April 2019. Hentz oversees ADC and Bioconjugation Platform development, including implementing bioconjugation laboratories, training colleagues, and managing multidisciplinary teams involving up to 10 chemists. Previous experience includes roles at Syndivia as a Scientific Investigator focusing on linker and payload design for ADCs, and various positions at Sanofi, including Head of HAPI Development Laboratory and Post-doctoral Researcher. Alexandre Hentz holds a Research Doctorate in Organic Chemistry from Paris-Sud University and extensive expertise in chemical synthesis and project management across both academic and industrial settings.